DK1933861T3 - Fremgangsmåde til behandling eller forebyggelse af multiorgansvigt - Google Patents

Fremgangsmåde til behandling eller forebyggelse af multiorgansvigt

Info

Publication number
DK1933861T3
DK1933861T3 DK06794084.1T DK06794084T DK1933861T3 DK 1933861 T3 DK1933861 T3 DK 1933861T3 DK 06794084 T DK06794084 T DK 06794084T DK 1933861 T3 DK1933861 T3 DK 1933861T3
Authority
DK
Denmark
Prior art keywords
treating
preventing
multiorgan failure
multiorgan
failure
Prior art date
Application number
DK06794084.1T
Other languages
English (en)
Inventor
Sirpa Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Application granted granted Critical
Publication of DK1933861T3 publication Critical patent/DK1933861T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06794084.1T 2005-10-07 2006-09-22 Fremgangsmåde til behandling eller forebyggelse af multiorgansvigt DK1933861T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20051003A FI20051003A0 (fi) 2005-10-07 2005-10-07 Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
PCT/FI2006/000308 WO2007042602A1 (en) 2005-10-07 2006-09-22 Method for treating or preventing ischemia reperfusion injury or multi-organ failure

Publications (1)

Publication Number Publication Date
DK1933861T3 true DK1933861T3 (da) 2012-10-15

Family

ID=35185146

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06794084.1T DK1933861T3 (da) 2005-10-07 2006-09-22 Fremgangsmåde til behandling eller forebyggelse af multiorgansvigt

Country Status (14)

Country Link
EP (1) EP1933861B1 (da)
JP (2) JP5523707B2 (da)
CN (1) CN101282741B (da)
AU (1) AU2006301186B2 (da)
CA (1) CA2623518C (da)
CY (1) CY1113404T1 (da)
DK (1) DK1933861T3 (da)
ES (1) ES2389507T3 (da)
FI (1) FI20051003A0 (da)
HK (1) HK1125048A1 (da)
PL (1) PL1933861T3 (da)
PT (1) PT1933861E (da)
SI (1) SI1933861T1 (da)
WO (1) WO2007042602A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2076533B1 (en) 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
FI20070795A0 (fi) 2007-10-24 2007-10-24 Faron Pharmaceuticals Oy Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
US8659835B2 (en) 2009-03-13 2014-02-25 Optotune Ag Lens systems and method
US8699141B2 (en) 2009-03-13 2014-04-15 Knowles Electronics, Llc Lens assembly apparatus and method
CN103228290A (zh) 2011-02-18 2013-07-31 (株)斯坦帝尔 包含沉默信息调节因子1表达诱导物质的败血症或者败血性休克的预防或者治疗用组合物
JP7470688B2 (ja) * 2018-12-04 2024-04-18 ファロン ファーマシューティカルズ オサケ ユキチュア Ｉ型インターフェロン治療に対する患者の反応性を特定する方法および特定一塩基多形を有する患者を治療するためのｉ型インターフェロンの使用
CA3206203A1 (en) * 2021-01-25 2022-07-28 Juho JALKANEN Treatment of diseases with sequential administration of an agent capable of up-regulating cd73 and glucocorticoids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60129472T2 (de) 2001-04-03 2008-04-17 U-Cytech B.V. Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon
WO2002089828A2 (en) * 2001-05-04 2002-11-14 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
US6894033B2 (en) * 2001-06-11 2005-05-17 Transition Therapeutics Inc. Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
WO2003024399A2 (en) * 2001-09-18 2003-03-27 The Johns Hopkins University Specific depletion of cd4+t cells
JP2005519946A (ja) * 2002-03-12 2005-07-07 マキシジェン エーピーエス 発作の処置のためのインターフェロンβ様分子
PL1608400T3 (pl) * 2003-03-28 2010-11-30 Faron Pharmaceuticals Oy Podwyższanie poziomu adenozyny przez indukowaną przez cytokiny ekspresję CD73

Also Published As

Publication number Publication date
EP1933861B1 (en) 2012-08-08
AU2006301186A1 (en) 2007-04-19
ES2389507T3 (es) 2012-10-26
PL1933861T3 (pl) 2012-12-31
CY1113404T1 (el) 2016-06-22
JP2013028623A (ja) 2013-02-07
EP1933861A1 (en) 2008-06-25
CA2623518A1 (en) 2007-04-19
JP2009511453A (ja) 2009-03-19
AU2006301186B2 (en) 2011-08-04
PT1933861E (pt) 2012-08-20
WO2007042602A1 (en) 2007-04-19
FI20051003A0 (fi) 2005-10-07
SI1933861T1 (sl) 2012-09-28
JP5523707B2 (ja) 2014-06-18
CA2623518C (en) 2014-11-18
CN101282741A (zh) 2008-10-08
CN101282741B (zh) 2012-08-15
HK1125048A1 (en) 2009-07-31
EP1933861A4 (en) 2009-07-01

Similar Documents

Publication Publication Date Title
DK2212070T3 (da) Fremgangsmåde til behandling af træ
DK1999225T3 (da) Fremgangsmåder til behandling af borehuller med genanvendelige fluider
DK1974806T3 (da) Fremgangsmåde til rensning af vand
DK3121169T3 (da) Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser
DK1830869T3 (da) Fremgangsmåde til behandling eller profylakse
DK1982005T3 (da) Fremgangsmåder til elektrolytisk fremstilling af erythrose eller erythritol
DK3136030T3 (da) Fremgangsmåde til lyofilisering
FI20055226A0 (fi) Menetelmä ja elementti palvelunohjaukseen
DK2188336T3 (da) Sammensætning omfattende et eller flere hydrofobt modificerede polyacrylamider og fremgangsmåde til anvendelse af sammensætningen
DK2054711T3 (da) Fremgangsmåde til fremstilling af mikroarrays
DK1846354T3 (da) Substituterede cyclopentaner eller cyclopentanoner til behandling af okular hypertensive tilstande
DE602006009605D1 (de) Verfahren zur Bearbeitung von Turbinenelementen
DK2215047T3 (da) Fremgangsmåde til behandling af vitamin b12-mangel
DE602007006721D1 (de) Waschsteuerungsverfahren
DK1917253T3 (da) Fremgangsmåde til fremstilling af betamimetika
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
NO346368B1 (no) En fremgangsmåte for konsentrasjon av alfa-mannosidase.
FI20061090A (fi) Kunnonvalvontamenetelmä
DK2252312T3 (da) Fremgangsmåder til forebyggelse eller behandling af insulinresistens
DE602006002419D1 (de) Eintauchverfahren
DK1905452T3 (da) Middel til forebyggelse eller behandling af glaukom
FI20065363A0 (fi) Erotusmenetelmä
DK1933861T3 (da) Fremgangsmåde til behandling eller forebyggelse af multiorgansvigt
FI20060178A0 (fi) Pinnoitusmenetelmä
DK2441462T3 (da) Fremgangsmåde til behandling af type I-diabetes